NEFRENE Trademark

Trademark Overview


On Tuesday, June 28, 2016, a trademark application was filed for NEFRENE with the United States Patent and Trademark Office. The USPTO has given the NEFRENE trademark a serial number of 87086919. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 20, 2018. This trademark is owned by Eli Lilly and Company. The NEFRENE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
nefrene

General Information


Serial Number87086919
Word MarkNEFRENE
Filing DateTuesday, June 28, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 20, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 1, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, August 20, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 20, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 5, 2018EXTENSION 2 GRANTED
Friday, January 5, 2018EXTENSION 2 FILED
Friday, January 5, 2018TEAS EXTENSION RECEIVED
Friday, July 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 13, 2017EXTENSION 1 GRANTED
Wednesday, June 21, 2017EXTENSION 1 FILED
Sunday, July 2, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 21, 2017TEAS EXTENSION RECEIVED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 17, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 12, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 5, 2016ASSIGNED TO EXAMINER
Friday, July 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 1, 2016NEW APPLICATION ENTERED IN TRAM